Insider Transactions in Q4 2022 at Point Biopharma Global Inc. (PNT)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 29
2022
|
Joe A. Mccann Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,160
+0.06%
|
$12,960
$6.64 P/Share
|
|
Nov 28
2022
|
Rajesh Malik Director |
BUY
Open market or private purchase
|
Direct |
3,700
+50.0%
|
$22,200
$6.66 P/Share
|
|
Nov 25
2022
|
Gerald L. Hogue Director |
BUY
Open market or private purchase
|
Direct |
3,660
+50.0%
|
$21,960
$6.82 P/Share
|
|
Nov 23
2022
|
David Charles Lubner Director |
BUY
Open market or private purchase
|
Direct |
3,600
+50.0%
|
$21,600
$6.85 P/Share
|
|
Nov 21
2022
|
Yael Margolin Director |
BUY
Open market or private purchase
|
Direct |
1,710
+50.0%
|
$10,260
$6.56 P/Share
|
|
Nov 18
2022
|
Allan C Silber Executive Chairman |
BUY
Open market or private purchase
|
Direct |
22,397
+0.52%
|
$134,382
$6.5 P/Share
|
|
Nov 18
2022
|
Jonathan R. Goodman Director |
BUY
Open market or private purchase
|
Indirect |
6,000
+12.53%
|
$36,000
$6.33 P/Share
|
|
Nov 17
2022
|
Allan C Silber Executive Chairman |
BUY
Open market or private purchase
|
Direct |
27,603
+0.65%
|
$165,618
$6.0 P/Share
|